TABIAT VA ILM-FAN KESISHMASIDA: GEN MUHANDISLIGI DUNYONI QUTQARADIMI YOKI XAVF SOLADIMI?
PDF

Keywords

gen muhandisligi, genom tahrirlash, CRISPR-Cas9, biotexnologiya, bioxavfsizlik, bioetika.

How to Cite

Gamzatova Gamzatovna, A., Rashidova Rashidovna, J., & Husnitdinova, N. (2026). TABIAT VA ILM-FAN KESISHMASIDA: GEN MUHANDISLIGI DUNYONI QUTQARADIMI YOKI XAVF SOLADIMI?. JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN UZBEKISTAN, 4(11), 8–12. Retrieved from https://scienceinno.org/index.php/jsiru/article/view/333

Abstract

Maqolada gen muhandisligi va genom tahrirlashning tibbiyot hamda qishloq xo‘jaligidagi imkoniyatlari tahlil qilinadi. Maqsad — CRISPR-Cas9 ning O‘zbekiston uchun ahamiyatini baholash. JSST, FAO, FDA va Fanlar akademiyasi manbalari qiyosiy o‘rganildi. Casgevy va mahalliy ekin liniyalari orqali foyda, xavf hamda nazorat talablari yoritildi.

PDF

References

1. WHO. Human genome editing: recommendations. Geneva, 2021

2. U.S. FDA. Human Gene Therapy Products Incorporating Human Genome Editing: Guidance, 2024. 3. U.S. FDA. CASGEVY: product information and approval history, 1 July 2026.

4. NHGRI. How Does Genome Editing Work?

5. FAO. Gene editing and agrifood systems, 2022; gene editing and food safety, 2023.

6. O‘zbekiston FA. 2024-yil faoliyati bo‘yicha yillik hisobot.

7. WHO. Genetically modified foods: questions and answers.

8. CBD. Biosafety Clearing-House: Uzbekistan profile, 13 April 2026. 9. Government of Uzbekistan. National Biosafety Initiative, 2 June 2026.

9. Government of Uzbekistan. National Biosafety Initiative, 2 June 2026.